NO for preterm infants at risk of bronchopulmonary dysplasia

Journal article

Peer reviewed

The Lancet (British edition), Vol.376(9738), pp.308-310

2010-07-31

PMID: 20655103

Abstract

Bronchopulmonary Dysplasia - drug therapy

Age Factors

Drug Administration Schedule

Bronchopulmonary Dysplasia - prevention & control

Humans

Administration, Inhalation

Free Radical Scavengers - administration & dosage

Treatment Outcome

Clinical Trials as Topic

Nitric Oxide - administration & dosage

Randomized Controlled Trials as Topic

Multicenter Studies as Topic

European Union

Infant, Premature

Infant, Newborn

11 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.37 Cardiology - General; 1.37.691 Pulmonary Hypertension
Web Of Science research areas: Pediatrics
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: NO for preterm infants at risk of bronchopulmonary dysplasia
Creators: Ilene R S Sosenko - Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101, USA
Eduardo Bancalari
Publication Details: The Lancet (British edition), Vol.376(9738), pp.308-310
Publisher: England
Academic Unit: Miller School of Medicine; UMMG Department of Pediatrics; UMMG Dept of Pediatrics - Neonatology
Language: English
Resource Type: Journal article
PMID: 20655103
Record Identifier: 991031560641302976